Exact form, route, and dosage not yet verified · Also known as: Lys-Pro-Val
Under review
KPV is listed in the CompoundedGuide registry with no verified FDA-approved product. FDA lists KPV among bulk drug substances for use in compounding that may present significant safety risks. KPV is not on FDA's 503B Bulks List for outsourcing facilities (list checked 2026-07-25). Identity and regulatory status are pending source collection and editorial review. This is not medical advice.
What we're checking
Is there an FDA-approved product?
Checking Drugs@FDA, Purple Book, Orange Book
What's the compounding status?
Checking FDA 503A/503B pages, Federal Register
Are there safety signals?
Checking FDA warnings, recalls, FAERS
What does the research show?
Checking ClinicalTrials.gov, PubMed
Sources we need
identity: FDA/NCATS GSRS or equivalent canonical identity source
product status: Drugs@FDA, Purple Book, Orange Book, DailyMed, or applicable primary FDA record
compounding status: FDA 503A/503B pages, Federal Register, docket, or applicable final/interim policy
safety: FDA safety communication, warning, recall, FAERS signal context, or explicit absence statement
evidence: ClinicalTrials.gov and PubMed/primary publication search
state or facility: State board or FDA facility record when relevant
Sources checked
Captured from the source and re-checked against it. Not yet editorially reviewed.